Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
V-0219 Hydrochloride
Cat. No.:
OB0425LY-135
Appearance:
Solid
Purity:
99.65%
Identity:
Confirmed by NMR and LC-MS.
Size:
Add to basket
Product Overview
Description:
V-0219 Hydrochloride is the hydrochloride salt form of V-0219, it is likely to maintain similar therapeutic effects and stability in formulation for studies focusing on metabolic diseases.
Synonyms:
2922283-73-4; V-0219 (hydrochloride)
CAS No.:
2922283-73-4
Compound CID:
166604052
Formula:
C20H26ClF3N4O2
Formula Weight:
446.89
Specification
Target:
GLP receptor
Pathway:
GPCR/G protein
Solubility:
DMSO
Storage:
Storage at 4°C.
Applications:
V-0219 Hydrochloride can be used in obesity-associated diabetes research.
